Nifty Hospitals Index

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Narayana Hrudayalaya has informed that the management of the Company will be meeting with the Analyst/Institutional Investors on June 26, 2026.

The above information is a part of company’s filings submitted to BSE.

Max Healthcare Institute has informed about the following with respect to Annual General Meeting, Record Date and Communication sent to members for deduction of tax at source on final dividend: 1) Annual General Meeting: The Twenty-Fifth Annual General Meeting (‘AGM’) of members of the Company is scheduled to be held on Thursday, July 30, 2026 through video conference / other audio-visual means, in accordance with the applicable circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India (‘SEBI’). 2) Record Date: Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed Friday, July 3, 2026, as the ‘Record Date’ for determining the members entitled to receive the final dividend for the financial year 2025-26, if approved by members at the ensuing 25th AGM. 3) Communication to member for deduction of tax at source on final dividend: The Company has today, June 19, 2026, sent a detailed communication to all members of the Company, whose e-mail addresses are registered with the Company/ depositories, indicating the process and documentation required for claiming exemption from deduction of tax at source on final dividend for the financial year 2025-26, which is subject to the approval of members at the ensuing 25th AGM. A copy of e-mail communication sent to members is enclosed as Annexure. This disclosure will also be hosted on Company's website: www.maxhealthcare.in.

The above information is a part of company’s filings submitted to BSE.

Global Health has informed that the Company’s Management will meet Investors/Analysts in Meetings organised by Nuvama Institutional Equities as on June 24, 2026, June 25, 2026 and June 26, 2026.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of the SEBI Listing Regulations, Aster DM Healthcare has informed that the Company today, i.e. June 18, 2026, has acquired 4,50,89,995 equity shares of Rs 10 each through rights issue in the Sarjapur Entity. The details as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are given in ‘Annexure I’. The above-mentioned information will also be available on the website of the Company at https://www.asterdmhealthcare.in.

The above information is a part of company’s filings submitted to BSE.

HealthCare Global Enterprises has informed that the directorate General of Health Services, Central Drugs Standard Control Organization (Ethics Committee Division) has issued an order dated June 12, 2026, (received on June 16, 2026) addressed to HCG Central Ethics Committee (located at HCG Towers, Tower-I, P. Kalinga Rao Road, Sampangi Rama nagar, Bangalore, 560027)(HCG KR Unit Ethics Committee), suspending HCG KR Unit Ethics Committee from approving or overseeing any new clinical trial for a period of 24 months.

The above information is a part of company’s filings submitted to BSE.